View in EDS HTML Full Text PDF Full Text

Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis.

Saved in:
Bibliographic Details
Title: Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis.
Authors: Jin, Yanyan1, Zhu, Jianhong2, Sheng, Aiqin1, Lin, Qian1, Zhao, Manli3, He, Xue1, Mao, Jianhua1, Fu, Haidong1 chfhd@zju.edu.cn
Source: Pediatric Nephrology. Aug2025, Vol. 40 Issue 8, p2561-2569. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0931041X
DOI:10.1007/s00467-025-06769-3